(Q40620303)

22 September 2017

title

Guidelines for the management of community-acquired pneumonia in Saudi Arabia: a model for the Middle East region (English)

1 reference

22 September 2017

0 references

1 reference

1 reference

1

Ziad A Memish

1 reference

22 September 2017

Atef M Shibl

2

1 reference

22 September 2017

Qanta A A Ahmed

series ordinal

3

1 reference

22 September 2017

Saudi Arabian Community-Acquired Pneumonia Working Group (SACAPWG)

series ordinal

4

1 reference

22 September 2017

publication date

1 January 2002

1 reference

International Journal of Antimicrobial Agents

22 September 2017

published in

1 reference

22 September 2017

volume

20 Suppl 1

1 reference

22 September 2017

page(s)

S1-12

1 reference

Translating practice guidelines into patient care : guidelines at the bedside

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

The cost of treating community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Frequency of subspecialty physician care for elderly patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Proportion of community-acquired pneumonia cases attributable to tobacco smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Serological investigation of pneumonia as it presents to the physician's office

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Chlamydia pneumoniae (TWAR).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Antibiotic resistance in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

A prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Applying a prediction rule to identify low-risk patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Pneumococcal drug resistance: the new "special enemy of old age".

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900243-1

7 January 2021

10.1016/S0924-8579(02)00243-1

Identifiers

DOI

1 reference

22 September 2017

1 reference